Table 2.
Hypoglycemic effects of anemarans were evaluated by sensitivity assay of NA and AA to exogenous insulin in insulin-resistant HepG2 cells
| Treatment | Concentration (μg/mL) | Glucose consumption (mmol/L) |
|---|---|---|
| Normal Control | 0 | 6.82±0.24 |
| Diabetic Control | 0 | 4.35±0.05 |
| NA | 1 | 6.43±0.98*a |
| 0.5 | 6.03±0.29*a | |
| 0.1 | 5.66±1.01*a | |
| 0.05 | 5.38±0.84 | |
| AA | 1 | 5.33±0.87 |
| 0.5 | 4.73±0.12 | |
| 0.1 | 4.47±0.18 | |
| 0.05 | 4.39±0.13 |
ap < 0.01: normal control (without insulin and anemaran treatment); *p < 0.05: Diabetic control (without anemaran treatment).